Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro

Clinical Orthopaedics and Related Research

Volumn 466, Issue 9, 2008, Pages 2168-2175

  Messerschmitt, Patrick J ^a   Rettew, Ashley N ^a   Brookover, Robert E ^a   Garcia, Ryan M ^a   Getty, Patrick J ^a   Greenfield, Edward M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DI TERT BUTYL ALPHA CYANO 4 HYDROXYTHIOCINNAMAMIDE; 5 (2 BENZOTHIAZOLYL)THIOMETHYL 4 HYDROXY 3 METHOXYBENZYLIDENECYANOACETAMIDE; 6,7 DIMETHOXY 2 PHENYLQUINOXALINE; DIPYRONE; EPIDERMAL GROWTH FACTOR RECEPTOR; N (3 CHLOROPHENYL) 3 [3,5 DIMETHYL 4 (4 METHYL 1 PIPERAZINYLCARBONYL) 1H PYRROL 2 YLMETHYLENE] 2,3 DIHYDRO N METHYL 2 OXO 1H INDOLE 5 SULFONAMIDE; PICROPODOPHYLLIN; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; PROTEIN TYROSINE KINASE; SOMATOMEDIN C RECEPTOR;

CANCER CELL CULTURE; CARCINOGENESIS; CELL MOTILITY; COLONY FORMATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; BONE TUMOR; CANCER INVASION; CANCER STEM CELL; CELL CULTURE; CELL MIGRATION ASSAY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; OSTEOSARCOMA; REVIEW; TUMOR CELL LINE;

BONE NEOPLASMS; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; OSTEOSARCOMA; PROTEIN-TYROSINE KINASES; RECEPTOR, IGF TYPE 1; TUMOR CELLS, CULTURED;

EID: 50649122547     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-008-0338-9     Document Type: Conference Paper

References (67)

1. T Akatsuka T Wada Y Kokai N Sawada S Yamawaki S Ishii 2001 Loss of ErbB2 expression in pulmonary metastatic lesions in osteosarcoma Oncology 60 361 366
2. A Albini Y Iwamoto HK Kleinman GR Martin SA Aaronson JM Kozlowski RN McEwan 1987 A rapid in vitro assay for quantitating the invasive potential of tumor cells Cancer Res 47 3239 3245
3. J Bain L Plater M Elliott N Shpiro CJ Hastie H McLauchlan I Klevernic JS Arthur DR Alessi P Cohen 2007 The selectivity of protein kinase inhibitors: a further update Biochem J 408 297 315
4. J Baselga 2006 Targeting tyrosine kinases in cancer: the second wave Science 312 1175 1178
5. S Benini N Baldini M Manara T Chano M Serra S Rizzi P Lollini P Picci K Scotlandi 1999 Redundancy of autocrine loops in human osteosarcoma cells Int J Cancer 80 581 588
6. V Betapudi L Licate T Egelhoff 2006 Distinct roles of nonmuscle myosin II isoforms in the regulation of MDA-MB-231 breast cancer cell spreading and migration Cancer Res 66 4725 4733
7. S Bielack B Kempf-Bielack G Delling G Exner S Flege K Helmke R Kotz M Salzer-Kuntschik M Werner W Winkelmann A Zoubek H Jurgens K Winkler 2002 Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols J Clin Oncol 20 776 790
8. S Burrow I Andrulis M Pollak R Bell 1998 Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcoma J Surg Oncol 69 21 27
9. R Charity A Foukas N Deshmukh R Grimer 2006 Vascular endothelial growth factor expression in osteosarcoma Clin Orthop Relat Res 448 193 198
10. P Cohen 2002 Protein kinases-the major drug targets of the twenty-first century? Nat Rev Drug Discov 1 309 315
11. N Coltella MC Manara V Cerisano L Trusolino MF Di Renzo K Scotlandi R Ferracini 2003 Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma Faseb J 17 1162 1164
12. X Duan S Jia Z Zhou R Langley M Bolontrade E Kleinerman 2004 Association of avb3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells Clin Exp Metastasis 21 747 753
13. SE Dunn RA Hardman FW Kari JC Barrett 1997 Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs Cancer Res 57 2687 2693
14. ML Edin AK Howe RL Juliano 2001 Inhibition of PKA blocks fibroblast migration in response to growth factors Exp Cell Res 270 214 222
15. R Ferracini MF Di Renzo K Scotlandi N Baldini M Olivero P Lollini O Cremona M Campanacci PM Comoglio 1995 The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit Oncogene 10 739 749
16. BB Freeman 3rd NC Daw JR Geyer WL Furman CF Stewart 2006 Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients Cancer Invest 24 310 317
17. T Fukuda E Ichimura T Shinozaki T Sano K Kashiwabara T Oyama T Nakajima T Nakamura 1998 Coexpression of HGF and c-Met/HGF receptor in human bone and soft tissue tumors Pathol Int 48 757 762
18. P Futreal L Coin M Marshall T Down T Hubbard R Wooster N Rahman M Stratton 2004 A census of human cancer genes Nat Rev Cancer 4 177 183
19. A Girnita L Girnita F del Prete A Bartolazzi O Larsson M Axelson 2004 Cycloligans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth ncer Res 64 236 242
20. R Gorlick A Huvos G Heller A Aledo G Beardsley J Healey P Meyers 1999 Expression of HER2/erbB-2 correlates with survival in osteosarcoma J Clin Oncol 17 2781 2788
21. A Gschwind O Fischer A Ullrich 2004 The discovery of receptor tyrosine kinases: targets for cancer therapy Nat Rev Cancer 4 361 370
22. D Hanahan R Weinberg 2000 The hallmarks of cancer Cell 100 57 70
23. A Handa T Tokunaga T Tsuchida Y Lee H Kijima H Yamazaki Y Ueyama H Fukuda M Nakamura 2000 Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma Int J Oncol 17 291 295
24. E Haura J Turkson R Jove 2005 Insights into the emerging role of signal transducers and activators of transcription in cancer Nat Clin Pract Oncol 2 315 324
25. J Hayden B Hoang 2006 Osteosarcoma: basic science and clinical implications Orthop Clin N Am 37 1 7
26. L Helman P Meltzer 2003 Mechanisms of sarcoma development Nat Rev Cancer 3 685 694
27. Herbst R, Onn A, Mendelsohn J. The role of growth factor signaling in malignancy. In: Frank D, ed. Signal Transduction in Cancer. Boston: Kluwer Academic Publishers; 2003:19-72.
28. D Hughes D Thomas T Giordano L Baker K McDonagh 2004 Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma Cancer Res 64 2047 2053
29. D Hughes D Thomas T Giordano K McDonagh L Baker 2006 Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 inhibition Pediatr Blood Cancer 46 614 623
30. S Jia L Worth E Kleinerman 1999 A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies Clin Exp Metastasis 17 501 506
31. MW Karaman S Herrgard DK Treiber P Gallant CE Atteridge BT Campbell KW Chan P Ciceri MI Davis PT Edeen R Faraoni M Floyd JP Hunt DJ Lockhart ZV Milanov MJ Morrison G Pallares HK Patel S Pritchard LM Wodicka PP Zarrinkar 2008 A quantitative analysis of kinase inhibitor selectivity Nat Biotechnol 26 127 132
32. M Katz I Amit A Citri T Shay S Carvalho S Lavi F Milanezi L Lyass N Amariglio J Jacob-Hirsch N Ben-Chetrit G Tarcic M Lindzen R Avraham YC Liao P Trusk A Lyass G Rechavi NL Spector SH Lo F Schmitt SS Bacus Y Yarden 2007 A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration Nat Cell Biol 9 961 969
33. M Kaya T Wada T Akatsuka S Kawaguchi S Nagoya M Shindoh F Higashino F Mezawa F Okada S Ishii 2000 Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis Clin Cancer Res 6 572 577
34. RJ Konrad RM Dean RA Young PC Billings BA Wolf 1996 Glucose-induced tyrosine phosphorylation of p125 in beta cells and pancreatic islets. A novel proximal signal in insulin secretion J Biol Chem 271 24179 24186
35. M Kovalenko A Gazit A Bohmer C Rorsman L Ronnstrand CH Heldin J Waltenberger FD Bohmer A Levitzki 1994 Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation Cancer Res 54 6106 6114
36. Y Lee T Tokunaga Y Oshika R Suto K Yanagisawa M Tomisawa H Fukuda H Nakano S Abe A Tateishi H Kijima H Yamazaki N Tamaoki Y Ueyama M Nakamura 1999 Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma Eur J Cancer 35 1089 1093
37. A Levitzki E Mishani 2006 Tyrphostins and other tyrosine kinase inhibitors Annu Rev Biochem 75 93 109
38. M Link A Goorin A Miser A Green C Pratt J Belasco J Pritchard J Malpas A Baker J Kirkpatrick 1986 The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity N Engl J Med 314 1600 1606
39. A Longhi C Errani M DePaolis M Mercuri G Bacci 2006 Primary bone osteosarcoma in the pediatric age: state of the art Cancer Treat Rev 32 423 436
40. H Luu Q Kang J Park W Si Q Luo W Jiang H Yin A Montag M Simon T Peabody R Haydon C Rinker-Schaeffer T He 2005 An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis Clin Exp Metastasis 22 319 329
41. PC Ma R Jagadeeswaran S Jagadeesh MS Tretiakova V Nallasura EA Fox M Hansen E Schaefer K Naoki A Lader W Richards D Sugarbaker AN Husain JG Christensen R Salgia 2005 An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis Cancer Res 65 1479 1488
42. EG MacEwen J Kutzke J Carew J Pastor JA Schmidt R Tsan DH Thamm R Radinsky 2003 c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells Clin Exp Metastasis 20 421 430
43. A Maitra D Wanzer AG Weinberg R Ashfaq 2001 Amplification of the HER-2/neu oncogene is uncommon in pediatric osteosarcomas Cancer 92 677 683
44. J Mendelsohn 2002 Targeting the epidermal growth factor receptor for cancer therapy J Clin Oncol 20 Suppl 1S 13S
45. CD Morris R Gorlick G Huvos G Heller PA Meyers JH Healey 2001 Human epidermal growth factor receptor 2 as a prognostic indicator in osteogenic sarcoma Clin Orthop Relat Res 382 59 65
46. Y Nakamura M Oka H Soda K Shiozawa M Yoshikawa A Itoh Y Ikegami J Tsurutani K Nakatomi T Kitazaki S Doi H Yoshida S Kohno 2005 Gefitinib ('Iressa,' ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance Cancer Res 65 1541 1546
47. Y Oda H Yamamoto S Tamiya S Matsuda K Tanaka R Yokoyama Y Iwamoto M Tsuneyoshi 2006 CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis Mod Pathol 19 738 745
48. M Ohmichi L Pang V Ribon A Gazit A Levitzki AR Saltiel 1993 The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor Biochem 32 4650 4658
49. M Onda S Matsuda S Higaki T Iijima J Fukushima A Yokokura T Kojima H Horiuchi T Kurokawa T Yamamoto 1996 ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma Cancer 77 71 78
50. N Osherov A Gazit C Gilon A Levitzki 1993 Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins J Biol Chem 268 11134 11142
51. M Park M Dean C Cooper M Schmidt S O'Brien D Blair GV Woude 1986 Mechanism of met oncogene activation Cell 45 895 904
52. S Patane S Avnet N Coltella B Costa S Sponza M Olivero E Vigna L Naldini N Baldini R Ferracini S Corso S Giordano PM Comoglio MF Di Renzo 2006 MET overexpression turns human primary osteoblasts into osteosarcomas Cancer Res 66 4750 4757
53. L Pedranzini T Dechow M Berishaj R Comenzo P Zhou J Azare W Bornmann J Bromberg 2006 Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells Cancer Res 66 9714 9721
54. S Peretz C Kim S Rockwell R Baserga PM Glazer 2002 IGF1 receptor expression protects against microenvironmental stress found in the solid tumor Radiat Res 158 174 180
55. P Peschard M Park 2007 From Tpr-Met to Met, tumorigenesis and tubes Oncogene 26 1276 1285
56. J Riedemann VM Macaulay 2006 IGF1R signalling and its inhibition Endocr Relat Cancer 13 Suppl 1 S33 43
57. A Sandberg J Bridge 2003 Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors Cancer Genet Cytogenet 145 1 30
58. M Sattler YB Pride P Ma JL Gramlick SC Chu LA Quinnan S Shirazian C Liang K Podar JG Christiansen R Salgia 2003 A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase Cancer Res 63 5462 5469
59. K Scotlandi MC Manara G Nicoletti PL Lollini S Lukas S Benini S Croci S Perdichizzi D Zambelli M Serra C Garcia-Echeverria F Hofmann P Picci 2005 Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors Cancer Res 65 3868 3876
60. I Sulzbacher M Traxler I Mosberger S Lang A Chott 2000 Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma Mod Pathol 13 632 637
61. JE Thompson RM Cubbon RT Cummings LS Wicker R Frankshun BR Cunningham PM Cameron PT Meinke N Liverton Y Weng JA DeMartino 2002 Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor Bioorg Med Chem Lett 12 1219 1223
62. K Trieb R Kotz 2001 Proteins expressed in osteosarcoma and serum levels as prognostic factors Int J Biochem Cell Biol 22 11 17
63. L Wang 2005 Biology of osteogenic sarcoma Cancer J 11 294 305
64. A Wells J Kassis J Solava T Turner DA Lauffenburger 2002 Growth factor-induced cell motility in tumor invasion Acta Oncol 41 124 130
65. YH Wen H Koeppen R Garcia L Chiriboga BD Tarlow BA Peters C Eigenbrot H Yee G Steiner MA Greco 2007 Epidermal growth factor receptor in osteosarcoma: expression and mutational analysis Hum Pathol 38 1184 1191
66. H Yang LR Yu M Yi DA Lucas L Lukes M Lancaster KC Chan HJ Issaq RM Stephens TP Conrads TD Veenstra KW Hunter 2006 Parallel analysis of transcript and translation profiles: identification of metastasis-related signal pathways differentially regulated by drug and genetic modifications J Proteome Res 5 1555 1567
67. Q Zhang Y Liu F Gao Q Ding C Cho W Hur Y Jin T Uno CA Joazeiro N Gray 2006 Discovery of EGFR selective 4,6-disubstituted pyrimidines from a combinatorial kinase-directed heterocycle library J Amer Chem Soc 128 2182 2183